1[1]Holtgrewe HL.Tramurethral prostatectomy.Urol Clin North Am,1995,12(2):357-363.
2[2]Puchner PJ.Miller MI.The effect of finasterid on hematuria associ ated with benign prostatic hyperplasia:a preliminary report.J Urol,1995.154:1779-1782.
3[3]Shih SJ,Dall-Era MA,Westphal JR,et al.Elements regularing angiogenesis and correlative mierovessel density in benign hyper plastic and malignat prostate tissue.Prostate Cancer Prostatic Dis,2003.6:131-137.
4[4]Baileyo DM,Foley SJ.Microvascular anatomy in patients with re current haematuria related to prostatic hypertrophy.J Urol,1999,161:865.
5[5]Mc Connell JD,Bruskewitz R,Walsh PC,et al.The effect of finesteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia:fi nasteride long tertn efficacy and safety study group.N Engl J Med,1998,338(4):557-563.
6[6]Foley SJ,Soloman Lz,Wedderbum AW,et al.A prospective atudy of the natural history of hematuria associated with benign prostatic hyperplasia and the effect of fimteride.J Urol,2000,163(2):496-498.
7[7]Haggstrom S,Toning N,Moller K,et al.Effects of finasteride on vascular endothelial growth factor.ScandJ Urol Nephrol,2002,36(3):182-187.
4Kramer G, Mitteregger D, Marberger M. Is benign prostatic hvpeplasia (BPH) an immune inflammatory disease?[J]. European urology, 2007, 51(5): 1202-1216.
5Gacci M, Salvi M, Sebastianeni A, et al. The use ofa single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction[J]. Research and reports in urologic, 2013, 5: 99.
6Zarowitz B J. Opportunity to Optimize Management of Benign Prostatic Hyperplasia[J]. Geriatric Nursing, 2010, 31(6): 441-445.
